Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Coastal Carolina Research Center in Goose Creek
1053
mi
from
Goose Creek, SC
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Coastal Carolina Research Center in Goose Creek
1053
mi
from
Goose Creek, SC
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
James T. Martin, Jr., M.D., OBGYN
1057
mi
from
North Charleston, SC
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
James T. Martin, Jr., M.D., OBGYN
1057
mi
from
North Charleston, SC
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Hillcrest Clinical Research, LLC
890
mi
from
Simpsonville, SC
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Hillcrest Clinical Research, LLC
890
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Midwest Medical Care
404
mi
from
Sioux Falls, SD
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Midwest Medical Care
404
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Associates
864
mi
from
Bristol, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Associates
864
mi
from
Bristol, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
ClinSearch, LLC
728
mi
from
Chattanooga, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
ClinSearch, LLC
728
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Alpha Clinical Research
587
mi
from
Clarksville, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Alpha Clinical Research
587
mi
from
Clarksville, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Memphis Gastroenterology Group
481
mi
from
Germantown, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Memphis Gastroenterology Group
481
mi
from
Germantown, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Associates in Gastroenterology
627
mi
from
Hermitage, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Associates in Gastroenterology
627
mi
from
Hermitage, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Associates Clinical Research
843
mi
from
Kingsport, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Associates Clinical Research
843
mi
from
Kingsport, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Dial Research Associates, INC
619
mi
from
Nashville, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Dial Research Associates, INC
619
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Columbia Medical Group -The First Clinic, Inc.
618
mi
from
Nashville, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Columbia Medical Group -The First Clinic, Inc.
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
TN Medical Research
580
mi
from
Spring Hill, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
TN Medical Research
580
mi
from
Spring Hill, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Research Across America/ Family Medicine Associates of Texas
330
mi
from
Carrollton, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Research Across America/ Family Medicine Associates of Texas
330
mi
from
Carrollton, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Corsicana Medical Research
399
mi
from
Corsicana, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Corsicana Medical Research
399
mi
from
Corsicana, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Texas University Health Sciences Center
639
mi
from
El Paso, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Texas University Health Sciences Center
639
mi
from
El Paso, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Pioneer Research Solutions
578
mi
from
Sugar Land, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Pioneer Research Solutions
578
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Houston S. Endoscopy and Research Center
565
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Houston S. Endoscopy and Research Center
565
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Digestive Associates of Houston
572
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Digestive Associates of Houston
572
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Consultants
580
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Consultants
580
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Spring Gastroenterology Associates
555
mi
from
Humble, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Spring Gastroenterology Associates
555
mi
from
Humble, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Digestive Health Associates of Texas
330
mi
from
Plano, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Digestive Health Associates of Texas
330
mi
from
Plano, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Sun Research Institute
575
mi
from
San Antonio, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Sun Research Institute
575
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Clinical Trials of Texas, Inc.
570
mi
from
San Antonio, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Clinical Trials of Texas, Inc.
570
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Panacea Clinical Research
576
mi
from
San Antonio, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Panacea Clinical Research
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Pioneer Research Solutions, Inc.
570
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Pioneer Research Solutions, Inc.
570
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Advanced Research Institute
789
mi
from
Ogden, UT
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Advanced Research Institute
789
mi
from
Ogden, UT
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Charlottesville Medical Reserch
1055
mi
from
Charlottesville, VA
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Charlottesville Medical Reserch
1055
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Associates of Tidewater
1186
mi
from
Chesapeake, VA
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Associates of Tidewater
1186
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology, Ltd.
1196
mi
from
Virginia Beach, VA
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology, Ltd.
1196
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Wisconsin Center for Advanced Research
633
mi
from
Milwaukee, WI
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Wisconsin Center for Advanced Research
633
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Aurora Advanced Healthcare, Inc-Clinical Research Center
637
mi
from
Milwaukee, WI
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Aurora Advanced Healthcare, Inc-Clinical Research Center
637
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Discovery Research
638
mi
from
West Bend, WI
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Discovery Research
638
mi
from
West Bend, WI
Click here to add this to my saved trials
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/12/2013
Santa Barbara Cottage Hospital
1242
mi
from
Santa Barbara, CA
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/12/2013
Santa Barbara Cottage Hospital
1242
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Status: Enrolling
Updated:  5/22/2013
Stanford Digestive Health Center
mi
from
Stanford, CA
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Status: Enrolling
Updated: 5/22/2013
Stanford Digestive Health Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy of Gralise® for Chronic Pelvic Pain
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated:  10/29/2013
Rehabilitation Institute of Chicago
611
mi
from
Chicago, IL
Efficacy of Gralise® for Chronic Pelvic Pain
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated: 10/29/2013
Rehabilitation Institute of Chicago
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Dietary Treatment of Crohn's Disease
Dietary Treatment of Crohn's Disease
Status: Enrolling
Updated:  1/24/2014
Gastroenterology Associates of Central Georgia
868
mi
from
Macon, GA
Dietary Treatment of Crohn's Disease
Dietary Treatment of Crohn's Disease
Status: Enrolling
Updated: 1/24/2014
Gastroenterology Associates of Central Georgia
868
mi
from
Macon, GA
Click here to add this to my saved trials
Dietary Treatment of Crohn's Disease
Dietary Treatment of Crohn's Disease
Status: Enrolling
Updated:  1/24/2014
Rush University Medical Center
608
mi
from
Chicago, IL
Dietary Treatment of Crohn's Disease
Dietary Treatment of Crohn's Disease
Status: Enrolling
Updated: 1/24/2014
Rush University Medical Center
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Weekly Vitamin D in Pediatric IBD
Weekly Vitamin D3 for Treatment of Hypovitaminosis D in Children and Adolescents With Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/3/2014
Children's Healthcare of Atlanta, Egleston Children's Hospital
801
mi
from
Atlanta, GA
Weekly Vitamin D in Pediatric IBD
Weekly Vitamin D3 for Treatment of Hypovitaminosis D in Children and Adolescents With Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/3/2014
Children's Healthcare of Atlanta, Egleston Children's Hospital
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Weekly Vitamin D in Pediatric IBD
Weekly Vitamin D3 for Treatment of Hypovitaminosis D in Children and Adolescents With Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/3/2014
Emory Children's Center
803
mi
from
Atlanta, GA
Weekly Vitamin D in Pediatric IBD
Weekly Vitamin D3 for Treatment of Hypovitaminosis D in Children and Adolescents With Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/3/2014
Emory Children's Center
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease
A Randomized Controlled Trial Comparing a Collaborative Cognitive Behavioral Therapy / Hypnotherapy Program to Standard Medical Management in the Treatment of Pediatric Functional Gastrointestinal Disease
Status: Enrolling
Updated:  5/14/2014
'Specially for Children, Dell Children's Medical Center of Central Texas
514
mi
from
Austin, TX
Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease
A Randomized Controlled Trial Comparing a Collaborative Cognitive Behavioral Therapy / Hypnotherapy Program to Standard Medical Management in the Treatment of Pediatric Functional Gastrointestinal Disease
Status: Enrolling
Updated: 5/14/2014
'Specially for Children, Dell Children's Medical Center of Central Texas
514
mi
from
Austin, TX
Click here to add this to my saved trials
Stress Management for Irritable Bowel Syndrome
Stress Management for Irritable Bowel Syndrome
Status: Enrolling
Updated:  6/18/2014
Wayne State University
841
mi
from
Detroit, MI
Stress Management for Irritable Bowel Syndrome
Stress Management for Irritable Bowel Syndrome
Status: Enrolling
Updated: 6/18/2014
Wayne State University
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Early Serum Infliximab Levels in Severe Ulcerative Colitis.
Early Serum Infliximab Levels in Severe Ulcerative Colitis
Status: Enrolling
Updated:  7/2/2014
University of California - San Francisco
1341
mi
from
San Francisco, CA
Early Serum Infliximab Levels in Severe Ulcerative Colitis.
Early Serum Infliximab Levels in Severe Ulcerative Colitis
Status: Enrolling
Updated: 7/2/2014
University of California - San Francisco
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status: Enrolling
Updated:  8/20/2014
New York State Psychiatric Institute, 1051 Riverside Drive
1286
mi
from
New York, NY
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status: Enrolling
Updated: 8/20/2014
New York State Psychiatric Institute, 1051 Riverside Drive
1286
mi
from
New York, NY
Click here to add this to my saved trials
Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens
Status: Enrolling
Updated:  10/2/2014
Nemours Children's Clinic
1056
mi
from
Jacksonville, FL
Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens
Status: Enrolling
Updated: 10/2/2014
Nemours Children's Clinic
1056
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
788
mi
from
Ogden, UT
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
788
mi
from
Ogden, UT
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
312
mi
from
Phoenix, AR
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
312
mi
from
Phoenix, AR
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
1164
mi
from
Artesia, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
1164
mi
from
Artesia, CA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
1154
mi
from
Orange, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
1154
mi
from
Orange, CA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
1130
mi
from
Riverside, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
1130
mi
from
Riverside, CA
Click here to add this to my saved trials